BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

BioSource International, Inc. (BIOI) Board Unanimously Rejects Bio-Rad Laboratories, Inc. (BIO) Offer


10/19/2005 5:13:16 PM

CAMARILLO, Calif.--(BUSINESS WIRE)--April 11, 2005--BioSource International, Inc. (Nasdaq:BIOI) today announced that its Board of Directors, in a special meeting held earlier today, voted unanimously to reject an unsolicited proposal from Bio-Rad Laboratories, Inc. (Amex:BIO) (Amex:BIOB), dated April 6, 2005, to acquire all of BioSource's outstanding shares at $8.50 per share in cash. The Board of Directors, after consultation with its legal and financial advisors, concluded that the proposed price is significantly below BioSource's inherent value. A copy of BioSource's letter to Bio-Rad regarding the Board of Directors' determination is attached to this press release. The BioSource Board of Directors also announced that BioSource has retained UBS Investment Bank to act as financial advisor and Weil, Gotshal & Manges to act as legal advisor, to assist the Company in evaluating strategic alternatives, including a possible sale of the Company. In addition, the Company said that its 2005 annual meeting, presently scheduled for May 24, 2005, will be rescheduled to a future date.

Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES